Form 4: BioAtla CEO Jay M. Short Acquires 431,000 Shares of Common Stock Through RSU Award

BioAtla's CEO, Jay M. Short, acquired 431,000 shares of common stock through a restricted stock unit (RSU) award, as reported in a recent SEC filing.

Summary

• Jay M. Short, the CEO of BioAtla, Inc., has acquired 431,000 shares of common stock.
• This acquisition was made through a time-based restricted stock unit (RSU) award.
• The RSU will vest as to 25% of the total number of shares on March 11, 2026.
• Thereafter, 6.25% of the total number of shares subject to the RSU shall vest on the last day of each May, August, November and February, contingent upon continued service.
• Following the transaction, Short directly owns 2,256,372 shares.
• Short also has indirect ownership through his spouse (793,547 shares), Carolyn Short 2020 Irrevocable Gift Trust (258,727 shares), Jay Short 2020 Irrevocable Gift Trust (258,727 shares), Capia IP, LLC (302,324 shares), and Himalaya Parent LLC (50 shares).

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard disclosure of an RSU grant, which is neither overtly positive nor negative. The CEO's acquisition of shares could be interpreted as a positive signal, but it's part of a pre-determined compensation plan.

Positives

• The acquisition of shares by the CEO could be seen as a positive sign, indicating confidence in the company's future prospects.

Future Outlook

The RSU award vests over time, contingent on continued service, suggesting a long-term commitment from the CEO.

Industry Context

Insider transactions are closely monitored as they can provide insights into management's perspective on the company's value and future performance. This Form 4 filing is a routine disclosure required by the SEC.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment, as it signals the CEO's continued commitment to the company.

Key Dates